Linda Van Aelst, Ph.D. | American Lung Association

Location Select your location

Linda Van Aelst, Ph.D.

Cold Spring Harbor Laboratory
Funded in partnership by the American Lung Association of the Northeast
Seeking Treatment to Stop Spread of Lung Adenocarcinoma

Detection of lung adenocarcinoma (ADC) is difficult and most patients are diagnosed at an advanced stage of the disease. Cancerous cells frequently metastasize, so that even when the tumor is removed from the lung, patients quickly relapse as the cancer spreads. These facts suggest that tumor cells seed distant organs prior to diagnosis or initial treatment. Therefore, effective treatments must target metastases. Little is known about how this process occurs. We have established an animal model for metastatic lung ADC that will allow us to identify and characterize the genes that drive growth of metastatic lung ADC tumors. Screening these potential drug targets against patient data will confirm which of these genes are clinically important.

Read more about Dr. Van Aelst's research.

Update: Over the past year, we have made significant progress toward the identification of genes associated with organ-specific lung ADC metastasis. We developed novel animal model systems that we are using to study organ-specific lung ADC metastases. These model systems allowed us to initiate genetic screens, which revealed genes that likely are involved in lung ADC metastatic cells that spread to the brain and bone.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.